Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Publication year range
1.
New Microbiol ; 23(1): 37-45, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10946404

ABSTRACT

The present study was carried out to gain insight into the mechanisms involved in the pathogenesis of streptococcal toxic shock syndrome (TSS) and other acute invasive diseases caused by Streptococcus pyogenes (GAS). Specifically, since both whole bacteria and their soluble products are often present in the blood in these conditions, we sought to detect possible synergic activities of somatic and extracellular products in inducing mediators release. For this purpose, whole blood cultures from healthy donors were incubated with different concentrations of streptococcal pyrogenic exotoxin A (SpeA), which is considered a major molecular effector of TSS, heat-killed GAS and cell-wall components such as lipoteichoic acid (LTA) and soluble peptidoglican (sPGN). Significant levels of TNF-alpha, IL-1 alpha and IFN-gamma were found in supernatants from cultures incubated with each of the four inducers alone. Whole GAS and both cell-wall components were more effective (p < 0.05) than SpeA in inducing cytokine release. Whole GAS, at weight basis, was a more potent inducer than LTA and sPGN and LTA, at weight basis, was a more potent inducer than sPGN. In order to verify possible additive or synergic effects of exotoxic and parietal compounds in inducing cytokine release, whole blood cells were incubated with mixtures of SpeA and LTA at different molecular ratio. TNF-alpha, IL-1 alpha and IFN-gamma levels in supernatants were significantly (p < 0.05) higher in supernatants of cultures stimulated simultaneously with the two components than those of cultures stimulated with a single agent. Moreover, these levels were significantly higher than the sum of cytokine levels induced by single components. This study shows that parietal compounds can act in synergy with exotoxins in inducing the release of cytokines, which appear to be the major mediators of TSS.


Subject(s)
Bacterial Proteins , Cytokines/biosynthesis , Exotoxins/immunology , Lipopolysaccharides/immunology , Membrane Proteins , Shock, Septic/immunology , Streptococcus pyogenes/metabolism , Teichoic Acids/immunology , Blood Cells , Cells, Cultured , Humans , Interferon-gamma/biosynthesis , Interleukin-1/biosynthesis , Shock, Septic/microbiology , Streptococcal Infections/immunology , Streptococcal Infections/microbiology , Tumor Necrosis Factor-alpha/biosynthesis
2.
Int J Antimicrob Agents ; 10(4): 285-9, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9916902

ABSTRACT

The bactericidal activities of macrolides (clarithromycin, roxithromycin and azithromicyn) and lansoprazole, alone and in combination, against Helicobacter pylori strains were evaluated. It was found that the association of lansoprazole and clarithromycin resulted in a marked synergism, while the combination of roxithromycin or azithromycin with lansoprazole had synergistic and additive effects.


Subject(s)
Anti-Bacterial Agents/pharmacology , Helicobacter pylori/drug effects , Omeprazole/analogs & derivatives , 2-Pyridinylmethylsulfinylbenzimidazoles , Azithromycin/pharmacology , Biopsy , Clarithromycin/pharmacology , Drug Synergism , Helicobacter pylori/isolation & purification , Humans , Kinetics , Lansoprazole , Microbial Sensitivity Tests/methods , Omeprazole/pharmacology , Roxithromycin/pharmacology , Time Factors
3.
Clin Diagn Lab Immunol ; 4(5): 607-10, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9302214

ABSTRACT

The lethal effects occurring in neonatal (<24-h-old) BALB/c mice after challenge with 25 mg of lipopolysaccharide (LPS) per kg of body weight were significantly counteracted by pretreatment with recombinant interleukin-10 (rIL-10; 25 or 50 ng/mouse). Concordantly, blockage of endogenous IL-10 with the SXC1 monoclonal antibody increased LPS-induced mortality. Both IL-10 and SXC1 modulated the release of tumor necrosis factor alpha (TNF-alpha) so that, relative to controls, peak TNF-alpha values after LPS challenge were decreased by rIL-10 and increased by anti-IL-10.


Subject(s)
Endotoxemia/drug therapy , Interleukin-10/therapeutic use , Animals , Animals, Newborn , Antibodies, Monoclonal/pharmacology , Endotoxemia/immunology , Interleukin-10/antagonists & inhibitors , Mice , Mice, Inbred BALB C , Recombinant Proteins/therapeutic use , Tumor Necrosis Factor-alpha/metabolism
4.
Infect Immun ; 65(5): 1683-7, 1997 May.
Article in English | MEDLINE | ID: mdl-9125547

ABSTRACT

The aim of this study was to examine the ability of Pseudomonas aeruginosa components to induce release of cytokines from human leukocytes. Human whole-blood cultures were incubated with several concentrations of purified P. aeruginosa products, including porins, exomucopolysaccharide, lipopolysaccharide, and toxin A. Supernatants were assayed for tumor necrosis factor alpha (TNF-alpha) and interleukin-6 (IL-6) activities. All of the P. aeruginosa components except toxin A were able to stimulate the release of both cytokines. On a weight basis, porins were as effective as lipopolysaccharide and significantly more effective than exomucopolysaccharide in inducing IL-6 release (P < 0.05). Moreover, porins were more potent than either exomucopolysaccharide or lipopolysaccharide in inducing TNF-alpha release (P < 0.05). Further experiments using isolated leukocytes suggested that monocytes were the cell population predominantly responsible for the production of both cytokines. These data indicate that P. aeruginosa porins are able to induce significant cytokine production. These components may be responsible for the chronically overactive inflammatory response associated with persistent lung infection in cystic fibrosis patients.


Subject(s)
Bacterial Toxins/pharmacology , Glycosaminoglycans/pharmacology , Interleukin-6/metabolism , Leukocytes, Mononuclear/metabolism , Leukocytes, Mononuclear/microbiology , Lipopolysaccharides/pharmacology , Porins/pharmacology , Pseudomonas aeruginosa/chemistry , Pseudomonas aeruginosa/immunology , Tumor Necrosis Factor-alpha/metabolism , B-Lymphocytes/immunology , B-Lymphocytes/metabolism , Bacterial Toxins/isolation & purification , Cells, Cultured , Electrophoresis, Polyacrylamide Gel , Glycosaminoglycans/isolation & purification , Granulocytes/immunology , Granulocytes/metabolism , Humans , Killer Cells, Natural/immunology , Killer Cells, Natural/metabolism , Kinetics , Lipopolysaccharides/isolation & purification , Monocytes/immunology , Monocytes/metabolism , Porins/isolation & purification , T-Lymphocytes/immunology , T-Lymphocytes/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...